In a cohort of 17 early de novo and 15 early-L-DOPA-treated PD patients as well as 22 healthy controls, brain PET imaging was performed using [11C]31 and the DAT-specific radioligand [11C]PE2I [155]. The gene discussed is SLC6A3; the disease is Parkinson disease.